Clinical Trials

1,174 enrolled 2 FDA

Phase 3 Active not recruiting

Triple Negative Breast Neoplasms

NCT05722015 2025-09-11

MK-3475A-D77

377 enrolled 17 charts 3 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03860844 2025-09-09

ISAKIDS

Phase 2 Terminated

67 enrolled 25 charts

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03646123 2025-08-28

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Phase 2 Terminated

255 enrolled 29 charts

Hodgkin Disease

NCT04174599 2025-04-20

Study to Compare the Efficacy and Safety of F-627 and GRAN®

242 enrolled 41 charts

Breast Neoplasms, Neutropenia

NCT03197935 2023-10-26

IMpassion031

333 enrolled 18 charts

Triple Negative Breast Neoplasms

NCT04584112 2023-03-15

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

83 enrolled

Triple Negative Breast Neoplasms

NCT03504410 2023-02-08

Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML

Phase 3 Terminated

200 enrolled 9 charts

Leukemia, Myeloid, Acute

NCT02190721 2021-12-10

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

50 enrolled 39 charts

Neutropenia

NCT03343145 2020-12-28

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

143 enrolled

Other hematologic neoplasmPlasma cell

Breast Neoplasms, Neutropenia

NCT00821249 2020-10-19

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

55 enrolled

Leukemia, Plasma Cell, Multiple Myeloma, Paraproteinemias, Plasmacytoma

NCT01248923 2020-09-30

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Other hematologic neoplasmPlasma cell

55 enrolled

Leukemia, Plasma Cell, Multiple Myeloma, Paraproteinemias, Plasmacytoma

NCT00462358 2020-09-28

A Study of ARRY-520 in Patients With Advanced Cancer

41 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

39 enrolled 16 charts

Breast Neoplasms, Neoplasms, Recurrence

NCT01858883 2019-07-18

Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors

Phase 1/2 Completed

55 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01031368 2019-03-01

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

29 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT01701323 2019-03-01

Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Terminated

7 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT02282215 2018-09-27

Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

163 enrolled

Fever, Infections, Leukemia, Neutropenia, Leukemia, Myeloid, Acute

NCT02521441 2018-02-23

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

138 enrolled

Neutropenia

NCT01822756 2018-02-12

An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors

Phase 1 Terminated

42 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01569087 2016-12-05

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

BreastClassical hematology

60 enrolled 17 charts

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

BreastClassical hematology

135 enrolled 18 charts

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01297543 2016-07-01

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Phase 1/2 Completed

45 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02805153 2016-06-20

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

Phase 4 Completed

215 enrolled

Breast Neoplasms

NCT02221492 2016-03-30

Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma

32 enrolled

Lymphoma

NCT02221479 2015-08-04

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

14 enrolled

Plasma cell

Multiple Myeloma

NCT01519700 2015-05-06

PIONEER

218 enrolled 15 charts

Breast Neoplasms, Neutropenia

NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

NCT01767714 2014-12-09

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

100 enrolled

Lymphoma, Non-Hodgkin

NCT01938456 2014-07-28

Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer

Phase 1 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01164475 2014-02-25

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

Phase 4 Completed

61 enrolled 19 charts

Lymphoma, Non-Hodgkin

NCT01079676 2012-10-16

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

220 enrolled

Neutropenia in Breast Cancer

NCT00004212 2012-05-16

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Oligodendroglioma, Recurrence, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

NCT00616213 2011-06-01

PR104 and G-CSF in Treating Patients With Solid Tumors

5 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00035620 2010-02-26

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

44 enrolled

Sarcoma

Bone Neoplasms, Neutropenia, Sarcoma

NCT00776165 2010-02-03

Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

126 enrolled

Chemotherapy-Induced Neutropenia

NCT00117897 2009-07-20

Treatment for Subjects With Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin, Neutropenia

NCT00114764 2008-10-31

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

84 enrolled

Leukemia, Myeloid, Neutropenia, Leukemia, Myeloid, Acute

NCT00117455 2008-05-16

A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

NCT00066092 2008-02-28

Pegfilgrastim PBPC Mobilization Study

41 enrolled